HCAT vs CTEV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 10, 2026

HCAT

44.3
AI Score
VS
HCAT Wins

CTEV

41.7
AI Score

Investment Advisor Scores

HCAT

44score
Recommendation
HOLD

CTEV

42score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric HCAT CTEV Winner
Forward P/E 7.764 5.2438 CTEV
PEG Ratio 0 0 Tie
Revenue Growth -12.7% 6.6% CTEV
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 44.3/100 41.7/100 HCAT
Profit Margin -90.6% -28.5% CTEV
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

HCAT 1M: -5.0% · 3M: +3.7% CTEV 1M: +1.9% · 3M: +12.3%

Current Technical Phase

HCAT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.4%), weak momentum, RSI 45

RSI (14): 44.9 · Price: $1.70

CTEV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (9.8% over 20 days), RSI 51

RSI (14): 50.6 · Price: $35.98

Fundamentals Snapshot

Metric HCAT CTEV
Market Cap
Forward P/E 215.2 4.9
Trailing P/E
Revenue (TTM)
Revenue Growth -0.1% 0.1%
Gross Margin 0.5% 0.7%
Operating Margin -0.1% 0.1%
EPS -3.68 -17.21
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, HCAT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.